Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1081232

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1081232

Tubeless Insulin Pump Market Size By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5150
Printable PDF (Multi User License)
USD 7150
Printable PDF (Enterprise User License)
USD 9150

Add to Cart

The tubeless insulin pump market is estimated to grow massively by 2030 owing to growing occurrences of diabetes around the world. In addition, escalating healthcare expenses associated with diabetes are projected to further propel market growth through the forecast timespan.

The tubeless insulin pump is an effective way to control diabetes through a Bluetooth-connected insulin management system that eliminates the need for daily insulin injections. Recent technological advances have improved pump systems by connecting tubeless insulin pumps to smartphone-type devices, which has fostered product outlook.

After the coronavirus outbreak, the burgeoning cost of insulin pumps due to worldwide supply chain disruptions impeded tubeless insulin pump market growth in the initial stages of the pandemic. However, collaborative efforts between private and public organizations have helped the market regain its pre-COVID momentum. For instance, in May 2021, Roche Diabetes Care, an innovative diabetes technologies services company, launched the mySugr Pump Control system embedded in the mySugr app to improve insulin pump therapy through smartphones.

To cite another instance, in January 2022, Insulet, a leading specialist in tubeless insulin pumps, received U.S. FDA approval for OmniPod 5, its tubeless automated insulin delivery (AID) system that can control daily insulin dosage according to the blood sugar level, in individuals over the age of six diagnosed with type 1 diabetes. The patch-like device can be easily controlled through a smartphone via the Dexcom G6 CGM (continuous glucose monitoring) system. Earlier, in July 2021, the OmniPod 5 AID system had reported successful results in a pivotal trial to reduce HbA 1c levels in children and adults with type 1 diabetes.

In another instance, in November 2021, Terumo Corporation, a medical device corporation, joined hands with a European company to enable MEDISAFE WITH, an insulin patch pump, that can be controlled by smartphone-type devices. The partnership was intended to help Terumo to enhance the operability of MEDISAFE WITH as well as normalize insulin pump therapy in the daily lives of patients.

The tubeless insulin pump market has been bifurcated based on end-use and region. In terms of end-use, the market has been further divided into hospitals & clinics, homecare, and others. The homecare segment dominated the market with more than 76% revenue share in 2021 as a result of technological advancements, growing product adoption, and soaring user preference.

In the regional landscape, apart from North America, Asia Pacific, and Europe, the RoW tubeless insulin pump market is projected to witness notable growth to be valued at around $50 million by 2030 due to the high prevalence of diabetes as well as mounting product uptake across various countries in the region.

Product Code: 2032

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definition
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Tubeless insulin pump industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 End-use trends
    • 2.1.3 Regional trends

Chapter 3 Tubeless Insulin Pump Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact factors
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of diabetes
      • 3.3.1.2 Technological advancements in tubeless insulin pump
      • 3.3.1.3 Increasing diabetes care expenditure
      • 3.3.1.4 Injuries caused by conventional & invasive insulin pumps
      • 3.3.1.5 Adoption of facilitative initiatives
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High long-term costs associated with tubeless insulin pump
      • 3.3.2.2 Stringent government regulations
  • 3.4 Growth potential analysis
    • 3.4.1 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2021
    • 3.8.1 Company matrix analysis, 2021
  • 3.9 PESTEL analysis

Chapter 4 Tubeless Insulin Pump Market, By End-use

  • 4.1 Key segment trends
  • 4.2 Home care
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Hospitals & clinics
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.4 Others
    • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Tubeless Insulin Pump Market, By Region

  • 5.1 Key regional trends
  • 5.2 North America
    • 5.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.2.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
  • 5.3 Europe
    • 5.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.3.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.4 UK
      • 5.3.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.5 Italy
      • 5.3.5.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.6 France
      • 5.3.6.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.7 Spain
      • 5.3.7.1 Market size, by end-use, 2017 - 2030 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.3 China
      • 5.4.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.4 Japan
      • 5.4.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.5 South Korea
      • 5.4.5.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.6 Australia
      • 5.4.6.1 Market size, by end-use, 2017 - 2030 (USD Million)
  • 5.5 RoW
    • 5.5.1 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 6 Company Profiles

  • 6.1 Competitive dashboard, 2021
  • 6.2 Insulet Corporation
    • 6.2.1 Business overview
    • 6.2.2 Financial data
    • 6.2.3 Product landscape
    • 6.2.4 Strategic outlook
    • 6.2.5 SWOT analysis
  • 6.3 Roche
    • 6.3.1 Business overview
    • 6.3.2 Financial data
    • 6.3.3 Product landscape
    • 6.3.4 Strategic outlook
    • 6.3.5 SWOT analysis
  • 6.4 Medtrum Technologies
    • 6.4.1 Business overview
    • 6.4.2 Financial data
    • 6.4.3 Product landscape
    • 6.4.4 Strategic outlook
    • 6.4.5 SWOT analysis
  • 6.5 Terumo Corporation
    • 6.5.1 Business overview
    • 6.5.2 Financial data
    • 6.5.3 Product landscape
    • 6.5.4 Strategic outlook
    • 6.5.5 SWOT analysis
  • 6.6 Zealand Pharma
    • 6.6.1 Business overview
    • 6.6.2 Financial data
    • 6.6.3 Product landscape
    • 6.6.4 Strategic outlook
    • 6.6.5 SWOT analysis
  • 6.7 MicroTech Medical Inc.
    • 6.7.1 Business overview
    • 6.7.2 Financial data
    • 6.7.3 Product landscape
    • 6.7.4 Strategic outlook
    • 6.7.5 SWOT analysis
Product Code: 2032

Data Tables

  • TABLE 1. Tubeless insulin pump industry 360 degree synopsis, 2017 - 2030
  • TABLE 2. Global tubeless insulin pump market, 2017 - 2021 (USD Million)
  • TABLE 3. Global tubeless insulin pump market, 2022 - 2030 (USD Million)
  • TABLE 4. Global tubeless insulin pump market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 5. Global tubeless insulin pump market, by end-use, 2022 - 2030 (USD Million)
  • TABLE 6. Global tubeless insulin pump market, by region, 2017 - 2021 (USD Million)
  • TABLE 7. Global tubeless insulin pump market, by region, 2022 - 2030 (USD Million)
  • TABLE 8. Industry impact forces
  • TABLE 9. Home care market size, by region, 2017 - 2021 (USD Million)
  • TABLE 10. Home care market size, by region, 2022 - 2030 (USD Million)
  • TABLE 11. Hospitals & clinics market size, by region, 2017 - 2021 (USD Million)
  • TABLE 12. Hospitals & clinics market size, by region, 2022 - 2030 (USD Million)
  • TABLE 13. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 14. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 15. North America tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 16. North America tubeless insulin pump market size, by country, 2022 - 2030 (USD Million)
  • TABLE 17. North America tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 18. North America tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 19. U.S. tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 20. U.S. tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 21. Canada tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 22. Canada tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 23. Europe tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 24. Europe tubeless insulin pump market size, by country, 2022 - 2030 (USD Million)
  • TABLE 25. Europe tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 26. Europe tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 27. Germany tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 28. Germany tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 29. UK tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 30. UK tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 31. France tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 32. France tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 33. Spain tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 34. Spain tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 35. Italy tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 36. Italy tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 37. Asia Pacific tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 38. Asia Pacific tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 39. Asia Pacific tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 40. China tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 41. China tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 42. Japan tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 43. Japan tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 44. South Korea tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 45. South Korea tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 46. Australia tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 47. Australia tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 48. RoW tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 49. RoW tubeless insulin pump market size, by country, 2022 - 2030 (USD Million)
  • TABLE 50. RoW tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 51. RoW tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach (supply side analysis)
  • FIG. 2 Data Validation
  • FIG. 3 Global tubeless insulin pump 360 degree synopsis, 2017 - 2030
  • FIG. 4 Industry segmentation
  • FIG. 5 Global tubeless insulin pump market size, 2017 - 2030 (USD Million)
  • FIG. 6 Growth potential analysis, by end-use
  • FIG. 7 Porter's analysis
  • FIG. 8 Competitive matrix analysis, 2021
  • FIG. 9 PESTEL analysis
  • FIG. 10 Key segment trends, by end-use
  • FIG. 11 Key regional trends
  • FIG. 12 Competitive dashboard, 2021
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!